Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: magazinearticle
|
![]() |
Lanadelumab Significantly Lowers Hereditary Angioedema Attacks vs BerotralstatThe clinical advisor, 2022-11COPYRIGHT 2022 Haymarket Media, Inc. ;ISSN: 1524-7317 ;DOI: 10.1016/j.anai.2022.08.580Full text available |
2 |
Material Type: magazinearticle
|
![]() |
Eylea for macular edemaMonthly prescribing reference, 2012-11, Vol.28 (11), p.A-13COPYRIGHT 2012 Haymarket Media, Inc. ;ISSN: 0883-0266Full text available |
3 |
Material Type: magazinearticle
|
![]() |
Berinert for angioedemaMonthly prescribing reference, 2009-11, Vol.25 (11), p.A-21COPYRIGHT 2009 Haymarket Media, Inc. ;ISSN: 0883-0266Full text available |
4 |
Material Type: magazinearticle
|
![]() |
Cinryze for angioedema.(NEWSLINE: Highlights of recent developments)Monthly prescribing reference, 2008-11, Vol.24 (11), p.A-10COPYRIGHT 2008 Haymarket Media, Inc. ;ISSN: 0883-0266Full text available |
5 |
Material Type: magazinearticle
|
![]() |
Hereditary Angioedema Prevention Tx ApprovedMonthly prescribing reference, 2018-10, Vol.34 (10), p.A6COPYRIGHT 2018 Haymarket Media, Inc. ;ISSN: 0883-0266Full text available |
6 |
Material Type: magazinearticle
|
![]() |
Haegarda Gains Approval for Hereditary AngioedemaMonthly prescribing reference, 2017-08, Vol.33 (7), p.A5COPYRIGHT 2017 Haymarket Media, Inc. ;COPYRIGHT 2017 Haymarket Media, Inc. ;ISSN: 0883-0266Full text available |
7 |
Material Type: magazinearticle
|
![]() |
Therapy shows efficacy, durable benefit, favorable safety profile: Triamcinolone acetonide injection approved for treatment of macular edemaOphthalmology times, 2021-12, Vol.46 (20), p.11COPYRIGHT 2021 Intellisphere, LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
8 |
Material Type: magazinearticle
|
![]() |
Tame the Swelling: Intravitreal pharmacotherapy is changing the treatment landscape for patients with macular edema and RVO.(Retina Dilemmas)Review of optometry, 2019-06, Vol.156 (6), p.28COPYRIGHT 2019 Jobson Medical Information LLC ;COPYRIGHT 2019 Jobson Medical Information LLC ;ISSN: 1930-160XFull text available |
9 |
Material Type: magazinearticle
|
![]() |
Aflibercept showing longer CME-free intervals in non-ischemic CRVOs: extended interval may help minimize patients' treatment burden, injectionsOphthalmology times, 2017-02, Vol.42 (3), p.30COPYRIGHT 2017 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
10 |
Material Type: magazinearticle
|
![]() |
Through Thick and Thin: Drug improves endothelial function but also yields corneal edemaReview of optometry, 2021-06, Vol.158 (6), p.84COPYRIGHT 2021 Jobson Medical Information LLC ;ISSN: 1930-160XFull text available |
11 |
Material Type: magazinearticle
|
![]() |
FDA approves Lucentis for diabetic macular edemaReview of optometry, 2012-09, Vol.149 (9), p.6COPYRIGHT 2012 Jobson Medical Information LLC ;ISSN: 1930-160XFull text available |
12 |
Material Type: magazinearticle
|
![]() |
Study favours Avastin over laser treatmentThe Optician, 2012-04, Vol.243 (6348), p.6Copyright Reed Business Information Limited Apr 20, 2012 ;ISSN: 0030-3968Full text available |
13 |
Material Type: magazinearticle
|
![]() |
Novel modality circumvents eye drop adherence concerns: Data provide further evidence for sustained-release intracanalicular dexamethasone insertOphthalmology times, 2019-01, Vol.44 (1), p.25COPYRIGHT 2019 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
14 |
Material Type: magazinearticle
|
![]() |
Study: corticosteroid does not benefit subset of patients with macular edema: intravitreal triamcinolone did not improve vision in those with presumed macular edemaOphthalmology times, 2007-08, Vol.32 (16), p.54COPYRIGHT 2007 Intellisphere, LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
15 |
Material Type: magazinearticle
|
![]() |
Corticosteroid trials give insights on efficacy; safety for DME treatment: Protocol U also may expand understanding of how steroids compare with anti-VEGF therapyOphthalmology times, 2017-10, Vol.42 (17), p.64COPYRIGHT 2017 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
16 |
Material Type: magazinearticle
|
![]() |
Bevacizumab stacks up for DME? Clinicians debate role, benefits of anti-VEGF therapy in treating diabetic macular edemaOphthalmology times, 2017-10, Vol.42 (16), p.44COPYRIGHT 2017 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
17 |
Material Type: magazinearticle
|
![]() |
NSAID use after dropless approach can help to lower CME rate: research compares dropless patients with those using traditional dropsOphthalmology times, 2017-03, Vol.42 (4), p.11COPYRIGHT 2017 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
18 |
Material Type: magazinearticle
|
![]() |
Variations of Rosacea Need Proper Therapy.(Health Fitness)Dermatology Times, 2000-01, Vol.21 (1), p.49COPYRIGHT 2000 MJH Life Sciences Media ;Copyright Advanstar Communications, Inc. Jan 2000 ;ISSN: 0196-6197 ;EISSN: 2150-6523 ;CODEN: DETIEGFull text available |
19 |
Material Type: magazinearticle
|
![]() |
Implant extends lasting effects for treatment of chronic DME: Fluocinolone acetonide approach helps reduce burden of repeated injectionsOphthalmology times, 2015-09, Vol.40 (15), p.44COPYRIGHT 2015 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |
20 |
Material Type: magazinearticle
|
![]() |
Real-world experience may guide intravitreal injection treatments: scenarios for when steroid implants may best serve as first- or second-line DME therapyOphthalmology times, 2015-03, Vol.40 (4), p.32COPYRIGHT 2015 UBM LLC ;ISSN: 0193-032X ;EISSN: 2150-7333Full text available |